BioCentury
ARTICLE | Distillery Therapeutics

eIF4E identified as target in obesity, fatty liver disease

April 7, 2021 12:12 AM UTC

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Obesity; liver disease...